http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-807590-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6801e6c30c29a2170075503f65a46da8
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C51-412
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C51-41
filingDate 1956-11-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3256bed59f9d4a8c367c12f5b9d09a04
publicationDate 1959-01-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber GB-807590-A
titleOfInvention Method for the preparation of organic salts of the rare earths, with good solubility in water, which possess an inhibitory action on blood coagulation
abstract The invention comprises rare earth metal laevulinates and the preparation thereof by reacting in solution laevulinic acid with an inorganic alkaline rare earth metal compound. The inorganic alkaline rare earth metal compound may be "didymium," neodymium, praseodymium, lanthanum or cerium carbonate or hydroxide. The process is preferably carried out by adding laevulinic acid to an aqueous solution of the inorganic alkaline rare earth metal laevulinate, e.g. in the case of adding laevulinic acid to aqueous "didymium" carbonate and then boiling for approximately 2 hours, the pH of approximately 6 may be obtained by adding carbonic acid or didymium carbonate. The rare earth metal laevulinates may be isolated from the resulting solutions by evaporation to dryness. In the examples "didymium," lanthanum and cerium laevulinares are prepared.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0564081-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0564081-A2
priorityDate 1956-11-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453167456
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419577471
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453937840
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID407832259
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID167103
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23926
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID767
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID409736587
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451361835
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID19660
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID961
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559568
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54600979
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID165369
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23974
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11579
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449310310
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419577485
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559376
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID168924

Total number of triples: 35.